Glenmark Pharmaceuticals Ltd.

GLENMARK Share PricePharmaceuticals & Drugs

₹2,181.1

277.1 (14.6%)

As on July 11, 2025

Exchange Scrips: BSE532296NSEGLENMARKISININE935A01035

Market Cap ₹ 61,572 Cr

P/E Ratio -40.99

Dividend Yield 0.11 %

Glenmark Pharmaceuticals Ltd. Performance

Market performance

Open2,094.4

High2,284.8

Volumes1,56,80,321

Prev2,181.1

Low2,094.4

As on2025-07-11

Historical performance

1 Year High2,284.8

3 Year High2,284.8

5 Year High2,284.8

1 Year Low1,275.5

3 Year Low360.45

5 Year Low348.5

Glenmark Pharmaceuticals Ltd. Fundamentals

Company Valuation

Market Cap (₹Cr)

61,572

Face Value (₹)

P/E Ratio

-40.99

Dividend Yield

0.11 %

Glenmark Pharmaceuticals Ltd. Investment Returns

1 Year

57.5%

3 Years

458.8%

5 Years

411.2%

10 Years

112%

Glenmark Pharmaceuticals Ltd. Technicals

Indicators	Value	Signal
5-DMA	1,918.9	Bullish
10-DMA	1,848.65	Bullish
20-DMA	1,764.38	Bullish
50-DMA	1,590.67	Bullish
100-DMA	1,498.89	Bullish
200-DMA	1,541.95	Bullish

Shareholding Pattern

Field	Mar-2025	Dec-2024	Sep-2024	Jun-2024	Mar-2024
Promoters	6	6	6	6	6
Foreign Investors	---	---	---	---	---
Domestic Investors	6	6	6	6	6
Public Investors	192718	195053	193943	192624	199445
Government	4	3	3	3	4

Glenmark Pharmaceuticals Ltd. Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

Negative

Neutral

Positive

The stock has a PE ratio of -40.99.
3Y Stock Price CAGR of the stock is 79.1.
The stock has a beta of 0.7.
In the last financial year, the company had an EBITDA of ₹20353 Million.
The company generated revenue of ₹118131 Million in the previous financial year.

Glenmark Pharmaceuticals Ltd.

2181.1277.1 (14.6%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1548911.7

No. of Shares: 710 (Approx)

Performance:54.9%

P/L: ₹548911.7

Top Gainers